Krka, Laurus Labs form JV to expand in new markets with focus on India
In a significant move within the pharmaceutical industry, Krka, a leading international generic pharmaceutical company based in Novo Mesto, Slovenia, and Laurus Labs (“Laurus” or ... Read More
Laurus Labs financial overview: Q2 and H1 FY24 revenue and earnings insights
Laurus Labs Ltd., a prominent pharmaceutical and biotech R&D entity in India, has released its H1 FY24 financial results. The firm reported a revenue of ... Read More
Laurus Labs expands stake in Immunoadoptive Cell Therapy for Rs.80cr
Hyderabad-based pharmaceutical company Laurus Labs has announced a significant investment in Immunoadoptive Cell Therapy (lmmunoACT), an advanced cell and gene therapy firm. The deal, valued ... Read More
Laurus Labs acquires stake in Indian CAR-T therapy developer ImmunoACT
Laurus Labs said that it has acquired a stake of 26.62% in Immunoadoptive Cell Therapy Private Limited (ImmunoACT), an Indian cell and gene therapy company ... Read More
Rising to launch generic version of Pregabalin Capsules in US
Rising Pharmaceuticals has launched a generic version of Lyrica, (pregabalin) Capsules in the US, in all eight commercially available strengths of 25 mg, 50 mg, ... Read More